No state is losing more traditional manufacturing jobs than North Carolina, as its furniture, textile, and tobacco industries continue to decline with many companies going overseas for cheap labor. Manufacturing employment in the state has plunged by 140,000 workers during the last three years…
Tag: <span>bioprocessing</span>
A significant percentage of new pharmaceutical commercialization activities now focus on biological-based therapeutics. This increasing demand for biologicals necessitates the continued expansion and technological improvement of bioprocessing activities. Bioprocessing plays a critical role throughout the entire drug commercialization process…
Optimization, flexibility, and competitive advantage normally aren’t used to describe warehousing operations in the pharmaceutical industry. However, as the industry continues to deal with difficult press, patent expirations, battles with Congress, and intense competition, even the historically unvarying business of warehousing is due for an overhaul…
Despite trepidations, bioprocess oursourcing has come a long way from its inception, which was born in necessity and regulatory fear. Based on primary research that Seraphim and Pharmsource conducted in 2002, the current market for biopharmaceutical manufacturing outsourcing (upstream and downstream production of bulk APIs, but excluding separately outsourced analytics, development, and other services) was $500 to $700 million with a projection to grow to $1.5 to $2.5 billion over the next five years…
